Innovative Molecular and Cellular Therapeutics in Cleft Palate Tissue Engineering

Area of Science:

• Craniofacial development and regenerative medicine.

Background:

• Orofacial clefts, particularly cleft palate, are common birth defects impacting ~1:700 births.
• Surgical correction is standard but often faces challenges, especially in severe cases, leading to lifelong complications.
• Current treatments may involve autologous bone grafts, carrying risks of donor-site morbidity.

Purpose of the Study:

• To review palate development, surgical challenges in cleft repair, and the role of osteoinductive pathways.
• To explore how tissue engineering and biomaterials can optimize cleft palate correction.
• To highlight novel osteogenic agents and delivery systems for regenerative approaches.

Main Methods:

• Literature review of palatogenesis, surgical techniques, and biomaterial applications.
• Analysis of osteoinductive pathways relevant to palate development.
• Discussion of innovative scaffolds and osteogenic agents for cleft repair.

Main Results:

• Palate development involves complex molecular signaling pathways crucial for successful fusion.
• Tissue-engineered scaffolds offer a promising alternative to autologous bone grafts.
• Novel biomaterials and growth factors are emerging for enhanced bone regeneration.

Conclusions:

• Tissue-engineered scaffolds hold significant potential for cleft palate repair by modulating molecular signaling.
• These approaches may overcome limitations of current surgical methods and autologous grafts.
• Interdisciplinary strategies combining biomaterials and drug delivery are transforming cleft palate treatment.